December 13, 2011

Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors

Key Points

Key points are not available for this paper at this time.

Abstract

RFA could be locally curative for HCC, resulting in survival for as long as 10 years, and was a safe procedure. RFA might be a first-line treatment for selected patients with early-stage HCC.

Bookmark

Cite This Study

Shiina et al. (Tue,) studied this question.

synapsesocial.com/papers/69dfecf6d5404a0bea59362e https://doi.org/https://doi.org/10.1038/ajg.2011.425

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Resection of hepatocellular carcinomas1990 · 83 citations
2Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma11No competing interests declared.2000 · 224 citations
3Estimating the world cancer burden: Globocan 20002001 · 3,748 citations
4[Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial].2006 · 201 citations
5Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series2006 · 323 citations